Uttaranchal Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.10 Cr
as on 24-10-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 20.12 Cr
as on 24-10-2024
- Revenue -7.07%
(FY 2023)
- Profit -22.16%
(FY 2023)
- Ebitda -5.62%
(FY 2023)
- Net Worth 21.90%
(FY 2023)
- Total Assets 19.13%
(FY 2023)
About Uttaranchal Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.10 Cr.
The company has closed loans amounting to ₹20.12 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Uttamchand Jain, Pravin Jain, Abhay Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233MH2005PLC369596
- Company No.
140455
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2005
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Uttaranchal Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Jain  | Director | 22-Sep-2008 | Current |
| Uttamchand Jain | Director | 24-Mar-2008 | Current |
| Pravin Jain | Director | 24-Mar-2008 | Current |
| Rahul Jain | Director | 22-Sep-2008 | Current |
Financial Performance of Uttaranchal Biotech.
Uttaranchal Biotech Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.07% decrease. The company also saw a substantial fall in profitability, with a 22.16% decrease in profit. The company's net worth Soared by an impressive increase of 21.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uttaranchal Biotech?
In 2023, Uttaranchal Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Surajlok Chemicals Private LimitedActive 33 years 11 monthsPravin Jain, Abhay Jain and 1 more are mutual person
Neon Laboratories LimitedActive 42 years 7 monthsUttamchand Jain, Pravin Jain and 1 more are mutual person
Korten Pharmaceuticals Private LimitedActive 34 years 2 monthsUttamchand Jain, Pravin Jain and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Oct 2013 | ₹5.00 Cr | Satisfied |
Canara Bank Creation Date: 15 Mar 2007 | ₹15.12 Cr | Satisfied |
How Many Employees Work at Uttaranchal Biotech?
Unlock and access historical data on people associated with Uttaranchal Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uttaranchal Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uttaranchal Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
